ASHLEY FLENER: Open Payments
NPI 1598311045 · LEITCHFIELD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 17 payments from 11 companies in 2025. Trend: 2023 $252 · 2024 $405 · 2025 $336
Food & beverage: $336
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Lilly USA, LLC | 2 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| Verona Pharma, Inc. | 2 | $30 |
| ABBVIE INC. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Ardelyx, Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
Products named: CAPLYTA, REPATHA, MOUNJARO, Ohtuvayre, VRAYLAR, VOQUEZNA, OTEZLA, IBSRELA.
Industry payments across KY — which companies pay providers there.
